Concord Biotech Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-10-28
Analyst
Kotak Securities
Equibles does not estimate personal net worth.
Alankar is recorded as Analyst at Kotak Securities. Alankar has spoken on 1 earnings call across 1 company, most recently for Concord Biotech Limited on October 28, 2026. The companies whose calls Alankar spoke on are classified in the Healthcare sector.
“Alankar's first-half growth top line is about 26%, and you had spoken about the 18% plus growth in FY27. Would you like to revisit the guidance?”
Kotak Securities
Analyst
Transcript header (unverified)
Concord Biotech Limited
Biotechnology · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Concord Biotech Limited